| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Humacyte, Inc. | Director | Stock Options (right to buy) | 80,000 | 12 Jun 2025 | Direct | ||
| Humacyte, Inc. | Director | Stock Options (right to buy) | 50,000 | 13 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HUMA | Humacyte, Inc. | 12 Jun 2025 | 1 | $0 | 4 | Director | 16 Jun 2025, 16:32 |
| HUMA | Humacyte, Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 17 Jun 2024, 16:12 |
| HUMA | Humacyte, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 16:11 |
| HUMA | Humacyte, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 16:21 |
| HUMA | Humacyte, Inc. | 13 Oct 2021 | 1 | $0 | 4 | Director | 15 Oct 2021, 15:37 |
| HUMA | Humacyte, Inc. | 26 Aug 2021 | 0 | $0 | 3 | Director | 27 Aug 2021, 16:06 |